Treatment of digitalis toxicity with intravenous potassium canrenoate.
作者信息
Gavrilescu G, Cristodorescu R, Deutsch G, Berger E
出版信息
Agressologie. 1977;18(3):167-71.
PMID:920909
Abstract
摘要
相似文献
1
Treatment of digitalis toxicity with intravenous potassium canrenoate.静脉注射钾螺内酯治疗洋地黄中毒。
Agressologie. 1977;18(3):167-71.
2
The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.静脉注射钾盐坎利酸钾对重度心力衰竭合并洋地黄中毒患者的影响。
Med Interne. 1977 Jan-Mar;15(1):27-34.
3
Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.坎利酮——螺内酯的一种代谢产物。对洋地黄化患者的急性心脏效应。
Eur J Cardiol. 1979 Aug;10(2):143-9.
4
[Use of canrenoate potassium given orally in ascitogenic cirrhosis].
Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):273-80.
5
6
[The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].[注射用抗醛固酮剂在继发性醛固酮增多症治疗中的应用]
Boll Soc Ital Cardiol. 1976;21(4):725-7.
7
[Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].[坎利酸钾-布噻嗪组合的降压疗效及对细胞内外电解质的影响]
Minerva Cardioangiol. 1988 Oct;36(10):503-7.
8
[Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):255-61.
9
[Study of the inotropic effect of potassium-canrenoate by systolic time intervals technique (author's transl)].用收缩期时间间期技术研究安体舒通钾的变力效应（作者译）
G Ital Cardiol. 1980;10(10):1360-5.
10
[Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].[安体舒通钾对原发性高血压患者动脉血压、血浆肾素活性及尿醛固酮的影响]
Boll Soc Ital Cardiol. 1978;23(10):1757-66.
Zotero 插件